Impact Of COVID 19 Outbreak On Global Human Rotavirus Vaccine Market 2020:Growth Analysis By Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, QIMR Berghofer Medical Research Institute, BIOVIRx Inc, Serum Institute of India Pvt. Ltd

Global human rotavirus vaccine market is expected to register a healthy CAGR of 11.7% in the forecast period of 2019-2026. This rise in the market can be attributed to the increase in the awareness regarding vaccines among patients, rise in the population of immunity-compromised individuals and rise in the geriatric population.

Few of the major market competitors currently working in the global human rotavirus vaccine market are Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc, Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, QIMR Berghofer Medical Research Institute, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma and others.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-human-rotavirus-vaccine-market

Insights of the Study

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the trocars market

Market Penetration: Comprehensive information on the product portfolios of the top players in the Human Rotavirus Vaccine market

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders

The key findings and recommendations highlight crucial progressive industry trends in the Human Rotavirus Vaccine Market, thereby allowing players to develop effective long term strategies

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Major Market Drivers and Restraints:

Growing awareness of vaccines among patients

Rising number of immunity-compromised individuals

Side effects and immune reaction

Strict regulatory requirements

High costs of vaccines

Market Segmentation:

By type the global human rotavirus vaccine market is segmented into Rotarix, Rotarix, Rotavac, Rotavin-M1, Lanzhou Lamb and others.

On the basis of end user the global human rotavirus vaccine market is segmented into hospitals, clinics, academic & research lab.

On the basis of distribution channel the global human rotavirus vaccine market is segmented into hospital pharmacies and drug stores.

On the basis of geography, global human rotavirus vaccine market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Inquire Regarding This Report https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-human-rotavirus-vaccine-market

FACTORS DRIVING GROWTH IN THE GLOBAL HUMAN ROTAVIRUS VACCINE MARKET

Increasing prevalence of rotavirus diseases:

Rotavirus has been the leading cause of severe diarrhea in infants and children. Rotaviruses are responsible to affect the populations in all socioeconomic groups and it is prevalent in industrialized as well as in developing countries. The rotavirus infection is highly transmittable and the people who are around the infected people are at high risk of infection.

The World Health organization (WHO), in 2016 estimated that globally 2,15,000 (1,97,000-2,33,000) child deaths occurred during 2013 due to rotavirus infection compared to 5,28,000 (4,65,000-5,91,000) in 2000. It also reported that 22.0% of deaths under 5 years of age occurred in India. Accompanied by India, Nigeria, Pakistan and the Democratic Republic of the Congo accounted approximately 49.0% of all deaths under the age of 5 in 2013.

Government Initiative:

As rotavirus infection has been the most common cause of severe diarrhea, many national authorities has taken initiatives to launch rotavirus vaccines in the market. India is one of the most affected countries by rotavirus. It is been studied that in India, rotavirus diarrhea causes 110,000 deaths amongst the annual over 450,000 deaths worldwide.

In India, in March 2015 Hon’ble Prime Minister Narendra Modi launched rotavirus vaccine Rotavac, developed by Hyderabad-based Bharat Biotech. In 2017, the Serum Institute of India Pvt. Ltd. revealed the result of clinical trial Phase 3 efficacy study of rotavirus vaccine BRV-PV, ROTASIIL. The study has showed that vaccine is safe, well tolerated, and to provide significant efficacy against severe rotavirus gastroenteritis. And therefore, Indian Government orders the vaccine for use in Universal Immunization Program.

Growing focus of market players

The global human rotavirus vaccine market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. The report also covers the market shares for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America market.

For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-human-rotavirus-vaccine-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.